Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01310114
Recruitment Status : Terminated (Study terminated by sponsor)
First Posted : March 8, 2011
Last Update Posted : March 1, 2018
Celgene Corporation
Information provided by (Responsible Party):
Celularity Incorporated

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 2013
  Actual Study Completion Date : March 2013
  Certification/Extension First Submitted : August 12, 2013